SciSparc Ltd. Banner Image

SciSparc Ltd.

  • Ticker SPRC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
SciSparc Ltd. Logo Image
  • 11-50 Employees
  • Based in Tel Aviv, Israel
SciSparc Ltd. (NASDAQ: SPRC) is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Their focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactiveMore cannabidiol (CBD): SCI-110 (formerly THX-110) for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; SCI-160 (formerly THX-160) for the treatment of pain; and SCI-210 (formerly THX-210) for the treatment of autism spectrum disorder and epilepsy.
4.7 / 5.0 (61)

SciSparc Ltd. reports have an aggregate usefulness score of 4.7 based on 61 reviews.

SciSparc Ltd.

Most Recent Annual Report

SciSparc Ltd.
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

SciSparc Ltd. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!